- Home
- TIL vs GMGI Comparison
TIL vs GMGI Comparison
Compare TIL & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- GMGI
- Stock Information
- Founded
- TIL 2018
- GMGI 2008
- Country
- TIL United States
- GMGI United States
- Employees
- TIL N/A
- GMGI N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- GMGI Computer Software: Prepackaged Software
- Sector
- TIL Health Care
- GMGI Technology
- Exchange
- TIL Nasdaq
- GMGI Nasdaq
- Market Cap
- TIL 230.1M
- GMGI 220.8M
- IPO Year
- TIL 2021
- GMGI N/A
- Fundamental
- Price
- TIL $31.69
- GMGI $1.64
- Analyst Decision
- TIL Buy
- GMGI Strong Buy
- Analyst Count
- TIL 5
- GMGI 1
- Target Price
- TIL $119.00
- GMGI $4.00
- AVG Volume (30 Days)
- TIL 263.6K
- GMGI 189.9K
- Earning Date
- TIL 08-12-2025
- GMGI 08-12-2025
- Dividend Yield
- TIL N/A
- GMGI N/A
- EPS Growth
- TIL N/A
- GMGI N/A
- EPS
- TIL N/A
- GMGI N/A
- Revenue
- TIL N/A
- GMGI $168,987,998.00
- Revenue This Year
- TIL N/A
- GMGI $28.44
- Revenue Next Year
- TIL N/A
- GMGI $18.24
- P/E Ratio
- TIL N/A
- GMGI N/A
- Revenue Growth
- TIL N/A
- GMGI 77.72
- 52 Week Low
- TIL $9.85
- GMGI $1.33
- 52 Week High
- TIL $92.00
- GMGI $3.06
- Technical
- Relative Strength Index (RSI)
- TIL 60.55
- GMGI 45.18
- Support Level
- TIL $25.58
- GMGI $1.58
- Resistance Level
- TIL $32.76
- GMGI $1.74
- Average True Range (ATR)
- TIL 2.55
- GMGI 0.11
- MACD
- TIL 0.75
- GMGI -0.01
- Stochastic Oscillator
- TIL 89.55
- GMGI 20.06
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.